These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15335447)

  • 21. [Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR].
    Ren L; Zhang B; Cao XC; Chen Y; Ge J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):445-8. PubMed ID: 20677155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genes, the environment, and breast cancer.
    Narod SA
    Lancet; 2010 Jun; 375(9732):2123-4. PubMed ID: 20617549
    [No Abstract]   [Full Text] [Related]  

  • 23. Integration of polymorphic data into the clinical management of breast cancer.
    Zubor P; Dokus K; Kajo K; Danko J
    Lancet Oncol; 2008 Dec; 9(12):1121-2. PubMed ID: 19038759
    [No Abstract]   [Full Text] [Related]  

  • 24. Polymorphisms of matrix metalloproteinases (MMP) gene and breast cancer risk: appraisal of a recent meta-analysis.
    Wu XY; Chen MB; Wang LQ; Xu Y; Tan Y; Shen WX
    Breast Cancer Res Treat; 2011 Nov; 130(1):357-8. PubMed ID: 21671019
    [No Abstract]   [Full Text] [Related]  

  • 25. SEPP1 and SEP15 gene polymorphisms and susceptibility to breast cancer.
    Mohammaddoust S; Salehi Z; Saeidi Saedi H
    Br J Biomed Sci; 2018 Jan; 75(1):36-39. PubMed ID: 28598259
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacogenomics in gynecology. Replies to the Zurich Discussion Panel].
    Huber JC; Schneeberger C; Noe M; Tempfer C
    Gynakol Geburtshilfliche Rundsch; 2003 Jan; 43(1):53-65. PubMed ID: 12561784
    [No Abstract]   [Full Text] [Related]  

  • 27. Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease-a pharmacogenomic approach.
    Iyer PM; Karthikeyan S; Sanjay Kumar P; Krishnan Namboori PK
    Funct Integr Genomics; 2017 Jul; 17(4):375-385. PubMed ID: 28470340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new susceptibility locus for estrogen receptor-negative breast cancer.
    Maduro MR
    Reprod Sci; 2012 Jan; 19(1):5. PubMed ID: 22228736
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetics in irritable bowel syndrome.
    Acosta A; Camilleri M
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1187-91. PubMed ID: 26122800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of breast cancer: toward the individualization of therapy.
    Chang JC; Hilsenbeck SG; Fuqua SA
    Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
    [No Abstract]   [Full Text] [Related]  

  • 31. Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer.
    Masoudi M; Saadat I; Omidvari S; Saadat M
    Breast Cancer Res Treat; 2010 Feb; 120(1):263-5. PubMed ID: 19731014
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients.
    Sini V; Botticelli A; Lunardi G; Gori S; Marchetti P
    Pharmacogenomics; 2017 Jun; 18(8):821-830. PubMed ID: 28592202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
    Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
    Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From Darwin's finches to canaries in the coal mine--mining the genome for new biology.
    Hunter DJ; Altshuler D; Rader DJ
    N Engl J Med; 2008 Jun; 358(26):2760-3. PubMed ID: 18579810
    [No Abstract]   [Full Text] [Related]  

  • 35. Methodological remarks concerning a recent meta-analysis on XPG Asp1104His and XPF Arg415Gln polymorphisms and breast cancer risk.
    Peng Q; Lao X; Li R; Qin X; Li S
    Breast Cancer Res Treat; 2013 Jun; 139(2):617-8. PubMed ID: 23619551
    [No Abstract]   [Full Text] [Related]  

  • 36. Polymorphisms in the ICAM gene locus are not associated with breast cancer Risk.
    Cox DG; Hankinson SE; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):178-9. PubMed ID: 16434609
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA-G polymorphism and breast cancer.
    Rolfsen GB; Castelli EC; Donadi EA; Duarte RA; Soares CP
    Int J Immunogenet; 2014 Apr; 41(2):143-8. PubMed ID: 24164707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental pollutants and breast cancer.
    Townson SM
    Cancer Invest; 2004; 22(3):474-6. PubMed ID: 15493368
    [No Abstract]   [Full Text] [Related]  

  • 39. Single nucleotide polymorphism (SNP) Thr241Met in the XRCC3 gene and breast cancer risk in Polish women.
    Romanowicz-Makowska H; Bryś M; Forma E; Maciejczyk R; Połać I; Samulak D; Michalska M; Smolarz B
    Pol J Pathol; 2012 Jun; 63(2):121-5. PubMed ID: 22864780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer.
    Cam R; Eroglu A; Egin Y; Akar N
    Breast Cancer Res Treat; 2009 May; 115(2):431-2. PubMed ID: 18498051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.